Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113


Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients.

Zhu J, Wu YN, Zhang W, Zhang XM, Ding X, Li HQ, Geng M, Xie ZQ, Wu HM.

PLoS One. 2014 Jan 30;9(1):e87904. doi: 10.1371/journal.pone.0087904. eCollection 2014.


Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.

Gao HJ, Zhao MC, Zhang YJ, Zhou DS, Xu L, Li GB, Chen MS, Liu J.

J Cancer Res Clin Oncol. 2015 Jul;141(7):1151-62. doi: 10.1007/s00432-014-1888-8. Epub 2014 Dec 2.


Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.

Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, Zhang Y, Hua S, Fu Q, Zhao M, Chen Y, Fang W, Lv X.

Cell Death Dis. 2014 Apr 10;5:e1155. doi: 10.1038/cddis.2014.122.


Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.

Mukudai Y, Kondo S, Fujita A, Yoshihama Y, Shirota T, Shintani S.

Cell Oncol (Dordr). 2013 Jun;36(3):233-45. doi: 10.1007/s13402-013-0131-y. Epub 2013 Mar 26.


Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.

Saito T, Kasamatsu A, Ogawara K, Miyamoto I, Saito K, Iyoda M, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.

PLoS One. 2015 Sep 17;10(9):e0137923. doi: 10.1371/journal.pone.0137923. eCollection 2015.


DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.

Fisel P, Kruck S, Winter S, Bedke J, Hennenlotter J, Nies AT, Scharpf M, Fend F, Stenzl A, Schwab M, Schaeffeler E.

Clin Cancer Res. 2013 Sep 15;19(18):5170-81. doi: 10.1158/1078-0432.CCR-13-1180. Epub 2013 Jul 23.


MIEN1 promotes oral cancer progression and implicates poor overall survival.

Rajendiran S, Kpetemey M, Maji S, Gibbs LD, Dasgupta S, Mantsch R, Hare RJ, Vishwanatha JK.

Cancer Biol Ther. 2015;16(6):876-85. doi: 10.1080/15384047.2015.1040962.


The chemokine receptor-CXCR2 plays a critical role in the invasion and metastases of oral squamous cell carcinoma in vitro and in vivo.

Qian Y, Wang Y, Li DS, Zhu YX, Lu ZW, Ji QH, Yang G.

J Oral Pathol Med. 2014 Oct;43(9):658-66. doi: 10.1111/jop.12189. Epub 2014 Jun 23.


miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.

Huang WC, Chan SH, Jang TH, Chang JW, Ko YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, Juang JL, Wang HC, Cheng AJ, Lu YC, Wang LH.

Cancer Res. 2014 Feb 1;74(3):751-64. doi: 10.1158/0008-5472.CAN-13-1297. Epub 2013 Dec 12.


Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.

Chang KP, Wang CL, Kao HK, Liang Y, Liu SC, Huang LL, Hseuh C, Hsieh YJ, Chien KY, Chang YS, Yu JS, Chi LM.

Cancer. 2013 Nov 15;119(22):4003-11. doi: 10.1002/cncr.28300. Epub 2013 Aug 20.


Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.

Dong C, Ye DX, Zhang WB, Pan HY, Zhang ZY, Zhang L.

J Oral Pathol Med. 2015 May;44(5):353-60. doi: 10.1111/jop.12296. Epub 2014 Dec 8.


Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.

Lin CY, Chen ST, Jeng YM, Yeh CC, Chou HY, Deng YT, Chang CC, Kuo MY.

J Oral Pathol Med. 2011 Oct;40(9):699-705. doi: 10.1111/j.1600-0714.2011.01019.x. Epub 2011 Feb 25.


Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.


Axl is a prognostic marker in oral squamous cell carcinoma.

Lee CH, Yen CY, Liu SY, Chen CK, Chiang CF, Shiah SG, Chen PH, Shieh YS.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S500-8. doi: 10.1245/s10434-011-1985-8. Epub 2011 Aug 13.


Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.

Gotanda Y, Akagi Y, Kawahara A, Kinugasa T, Yoshida T, Ryu Y, Shiratsuchi I, Kage M, Shirouzu K.

Anticancer Res. 2013 Jul;33(7):2941-7.


Role of EZH2 in oral squamous cell carcinoma carcinogenesis.

Zhao L, Yu Y, Wu J, Bai J, Zhao Y, Li C, Sun W, Wang X.

Gene. 2014 Mar 10;537(2):197-202. doi: 10.1016/j.gene.2014.01.006. Epub 2014 Jan 11.


Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.

Wu HM, Cao W, Ye D, Ren GX, Wu YN, Guo W.

Mol Med Rep. 2012 Aug;6(2):265-70. doi: 10.3892/mmr.2012.910. Epub 2012 May 9.


Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells.

Katase N, Lefeuvre M, Tsujigiwa H, Fujii M, Ito S, Tamamura R, Buery RR, Gunduz M, Nagatsuka H.

Oncol Rep. 2013 Apr;29(4):1349-55. doi: 10.3892/or.2013.2251. Epub 2013 Jan 24.


Expression of growth arrest and DNA damage inducible 45a in human oral squamous cell carcinoma is associated with tumor progression and clinical outcome.

Zhang XY; Xun-Qu, Wang CQ, Liu GX, Zhou CJ, Wang ZG.

J Cancer Res Ther. 2014 Nov;10 Suppl:C108-13. doi: 10.4103/0973-1482.145811. Erratum in: J Cancer Res Ther. 2015 Aug;11 Suppl 1:C140.

Items per page

Supplemental Content

Support Center